• OPEN AN ACCOUNT
Indian Indices
Nifty
24,426.85 -74.05
(-0.30%)
Sensex
80,223.32 413.67
( 0.52%)
Bank Nifty
53,655.65 -164.70
( -0.31%)
Nifty IT
35,181.25 -307.50
( -0.87%)
Global Indices
Nasdaq
45,566.70 -91.21
(-0.20%)
Dow Jones
6,481.27 -41.59
(-0.64%)
Hang Seng
42,764.54 -64.25
(-0.15%)
Nikkei 225
9,187.34 -29.48
(-0.32%)
Forex
USD-INR
87.60 0.00
(0.00%)
EUR-INR
102.16 0.00
(0.00%)
GBP-INR
118.33 0.00
(0.00%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

BSE Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
538397
INE118H01025
92.2771967
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BSE
59.33
85132.78
EPS(TTM)
Face Value()
Div & Yield %
35.33
2
1.1
 

Pfizer jumps after robust Q1 earnings
Aug 14,2025
On a standalone basis, net profit rose 27.23% year-on-year to Rs 191.75 crore in Q1 FY26 from Rs 150.71 crore in Q1 FY25, but fell 3.3% sequentially from adjusted net profit of Rs 198.33 crore in Q4 FY25.

Revenue from operations stood at Rs 603.05 crore, up 7.14% YoY from Rs 562.86 crore and 1.88% higher than Rs 591.91 crore in the March quarter.

Profit before tax and exceptional items stood at Rs 259.53 crore in Q1 FY26, up 28.09% YoY and up 2.59% from Rs 252.99 crore in Q4 FY25.

Total expenditure rose 1.99% YoY to Rs 393.03 crore from Rs 385.37 crore and was up 7.86% sequentially from Rs 364.41 crore. Cost of material consumed jumped 53.60% YoY to Rs 88.69 crore in Q1 FY26.

Pfizer is one of the world’s leading pharmaceutical companies, specialising in four key business categories — vaccines, hospitals, internal medicine, and inflammation & immunology.